XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock options activity

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contract

Intrinsic

    

Stock Options

    

Price

    

Term (Yrs.)

    

Value

Outstanding at December 31, 2021

 

1,377,339

$

16.13

 

3.37

$

2,579,201

Granted

 

65,000

11.80

 

 

Forfeited

 

(12,457)

21.37

 

 

Exercised

 

 

 

Expired

 

 

 

 

Outstanding at March 31, 2022

 

1,429,882

$

15.89

 

3.48

$

21,950

Vested and exercisable at December 31, 2021

 

648,119

$

11.64

 

2.77

$

2,407,521

Vested and exercisable at March 31, 2022

 

738,640

$

12.50

 

2.72

$

21,950

Schedule of weighted average assumptions to estimate the fair value of stock options

Three Months Ended March 31, 

 

Weighted Average Assumptions:

    

2022

    

2021(a)

 

Expected dividend yield

 

0.0

%  

%

Expected equity volatility

 

65.6

%  

%

Expected term (years)

 

5

 

Risk-free interest rate

 

1.58

%  

%

Exercise price per stock option

$

11.80

$

Market price per share

$

11.80

$

Weighted average fair value per stock option

$

6.55

$

(a)     There were no stock options granted during the three months ended March 31, 2021.